(June 2016). Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting FactorXa. Clinical Pharmacokinetics55 (6): 641–55. PMID26620048. PMC4875962. DOI: 10.1007/s40262-015-0342-7.
(en) Giugliano, Robert P., Christian T. Ruff, M.D., M.P.H., Eugene Braunwald, M.D., Sabina A. Murphy, M.P.H., Stephen D. Wiviott, M.D., Jonathan L. Halperin, M.D., Albert L. Waldo, M.D., Michael D. Ezekowitz, M.D., D.Phil., Jeffrey I. Weitz, M.D., Jindřich Špinar, M.D., Witold Ruzyllo, M.D., Mikhail Ruda, M.D. (2013). Edoxaban versus Warfarin in Patients with Atrial Fibrillation. New England Journal of Medicine 369
nih.gov
ncbi.nlm.nih.gov
(June 2016). Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting FactorXa. Clinical Pharmacokinetics55 (6): 641–55. PMID26620048. PMC4875962. DOI: 10.1007/s40262-015-0342-7.